Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06916104
Enrolling by invitation Observational

Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy

NCT06916104 · tracked via the Priya Life Science France tracker
Sponsor
Poitiers University Hospital
Phase
Observational
Started
2024-03-01
Last updated
2025-04-08

Condition(s) studied

Severe AsthmaBiotherapyRespiratory Allergy

Investigational drug(s) / intervention(s)

search for respiratory allergies

search for respiratory allergies: analyses in terms of biotherapy and respiratory allergy

Study summary

The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of factors predictive of response to biotherapy. The main aim is to improve the management of adult severe asthma patients treated with biotherapy, according to their allergic status.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Severe asthma patient on biotherapy * Age \> or = 18 years * Follow-up at Poitiers University Hospital Exclusion Criteria: * Absence of allergological assessment * Patient's refusal to participate in study

Primary outcome measure(s)

  • Find out whether a positive respiratory allergy test influences the efficacy of one or more biotherapies — 1 year

Trial sites (1)

FacilityCityRegionStatus
Chu Poitiers Poitiers France

More Poitiers University Hospital trials in France

What is the Role of the Exposome in Pulmonary Hypertension Starting soon
Weaning From High Flow Nasal Oxygen in Acute Respiratory Failure : a Target Trial Emulation Active, not recruiting
CAR-T Immunomonitoring in Multiple Myeloma (CART I5M) Recruiting
Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial Recruiting
Interventions to Remedy the Negative Effects of Obesity Stigma Recruiting

Other trials for the same condition

Cohort Analysis of Clinical and Biological Severe Childhood Asthma Active, not recruiting
Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins Starting soon
Deployment o the Multidisciplinary Prospective Cohort Imminent Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) Recruiting
Predictive Signature of Benralizumab Response Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06916104 on ClinicalTrials.gov ↗ ← All trials in France